Monthly Archives: September 2025

Jamjoom Pharma and Iraqi Dermatology Society Sign MoU to Transform Skin Health Awareness

Jamjoom Pharma and Iraqi Dermatology Society Sign MoU to Transform Skin Health Awareness Baghdad, Iraq – 25 September, 2025 – The Iraqi Dermatology Society and Jamjoom Pharma have signed a Memorandum of Understanding (MoU) to collaborate on a nationwide awareness initiative, ECZPLORE, aiming at supporting patients, caregivers, and healthcare professionals in the fight against eczema…

Jamjoom Pharma Strikes Strategic Deal with Bio-Thera for securing Cosentyx® Biosimilar in MENA

Jamjoom Pharma Strikes Strategic Deal with Bio-Thera for securing Cosentyx® Biosimilar in MENA Jeddah, Saudi Arabia –15 September, 2025 – Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma), one of the fastest-growing pharmaceutical companies in the Middle East and Africa, announced the signing of a strategic commercialization agreement with Bio-Thera Solutions, Ltd. (688177:SH), a global biopharmaceutical company…